Epicrispr Biotechnologies vs mbiomics
Epicrispr Biotechnologies vs mbiomics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and mbiomics on 48/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 48/100
- domain rating: 40/100 against 9/100
- funding raised: $90.0M against $12.0M
mbiomics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epicrispr Biotechnologies | mbiomics |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Advancing scalable microbiome-based therapeutics for severe and chronic diseases. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Pharmaceuticals, Healthcare, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2020 |
| Headquarters | South San Francisco, United States | Munich, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | mbiomics |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $12.0M |
| Latest round | Series C | Series A |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | mbiomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 48/100 |
| Traction | 57/100 | 35/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 20/100 | 2/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 9/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | mbiomics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Framer |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs mbiomics: common questions
Which is better, Epicrispr Biotechnologies or mbiomics?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and mbiomics compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 48/100), domain rating (40/100 against 9/100), funding raised ($90.0M against $12.0M).
Read the full Epicrispr Biotechnologies review and pricing or the mbiomics review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.